Study Summary
The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy
Eligible Conditions
- Intractable Epilepsy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: Baseline, post intervention (about 2 hours after baseline )
Hour 2
Change in amplitude of evoked potentials metrics as assessed by the scalp EEG
Electroencephalography
Hour 2
Change in reaction time to visual stimuli measured as vigilance score assessed by the Psychomotor Vigilance test (PVT)
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Treatment
1 of 1
Experimental Treatment
25 Total Participants · 1 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Treatment
Device
Experimental Group · 1 Intervention: RNS/DBS activation · Intervention Types: DeviceTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post intervention (about 2 hours after baseline )
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
809 Previous Clinical Trials
256,160 Total Patients Enrolled
Sandipan Pati, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS).
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments